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Abstract
Objectives: The expression of inflammatory molecules is regulated by 
the transcription factor activator protein-1 (AP-1), a heterodimeric protein 
that consists of proteins from various families, including c-Jun and c-Fos. 
We sought to elucidate whether MgSO4 regulates the activation of AP-1 in 
endotoxin-activated RAW264.7 cells, a murine macrophage-like cell line. 
The possible roles of the L-type calcium channels in this process were also 
elucidated.
Materials and Methods: RAW264.7 cells were treated with phosphate 
buffered saline, MgSO4, lipopolysaccharide (LPS), LPS plus MgSO4 (20 mM), 
or LPS plus MgSO4 plus the L-type calcium channel activator BAY-K8644 
(1 μM). After harvesting, expression of AP-1 was evaluated.
Results: LPS induced AP-1 activation based on the fact that the nuclear 
protein concentrations of AP-1 components, including c-Jun and c-Fos, as 
well as the AP-1 DNA-binding activity, were significantly increased in LPS-
treated RAW264.7 cells. MgSO4, in contrast, significantly inhibited LPS-
induced AP-1 activation in activated RAW264.7 cells. Moreover, the effect 
of MgSO4 on AP-1 was reversed by BAY-K8644.
Conclusion: MgSO4 inhibited AP-1 activation in LPS-treated macrophages 
and the mechanism may involve the L-type calcium channels. [Tzu Chi 
Med J 2010;22(4):177–183]
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1. Introduction
Upregulation of inflammatory molecules is essential in 
mediating the development of systemic inflammatory 
responses during sepsis [1]. Therapies aimed at de-
creasing inflammatory molecule expression have been 
shown to be effective in reducing the pathological se-
quelae of sepsis [2]. Transcription factors, including 
nuclear factor-κB (NF-κB) and activator protein-1 (AP-1), 
are essential for the production of endotoxin-induced 
inflammatory molecules [3,4]. AP-1 is a hetero dimeric 
protein that consists of proteins from various families, 
including c-Jun, c-Fos and others [5].
Magnesium sulfate (MgSO4) is an anticonvulsant 
that is used for the treatment of severe preeclampsia 
and eclampsia [6]. MgSO4 also reduces intraopera-
tive anesthetic requirements and is effective in con-
trolling neuropathic pain [7,8]. Moreover, MgSO4 has 
178 TZU CHI MED J  December 2010  Vol 22  No 4
been shown to possess certain anti-inflammation ef-
fects. Our previous data [9], in agreement with other 
investigations [10], confirmed that MgSO4 significantly 
suppressed the inflammatory responses in cells treated 
with endotoxin. MgSO4 has also been reported to 
suppress NF-κB activation [9,10].
However, the effects of MgSO4 on regulating the acti-
vation of AP-1 remain unstudied. To elucidate further, 
we thus conducted this cellular study based on the 
hypothesis that MgSO4 is able to inhibit the activation 
of AP-1 in endotoxin-activated murine macrophages. 
In addition, it is known that magnesium is a potent 
L-type calcium channel inhibitor [11]. Our previous 
results have demonstrated the involvement of L-type 
calcium channels in mediating the anti-inflammation 
effects of MgSO4 [9]. Therefore, in this study, we inves-
tigated the possible role of the L-type calcium channels 
with respect to MgSO4 and the activation of AP-1.
2. Materials and methods
2.1. Cell culture and cell activation 
protocols
RAW264.7 cells, an immortalized murine macrophage-
like cell line, is able to readily express inflammatory 
molecules upon stimulation by endotoxin [12]. Based 
on this fact, we employed RAW264.7 cells in this inves-
tigation. RAW264.7 cells were grown in Dulbecco’s 
modified Eagle’s medium (Life Technologies, Grand 
Island, NY, USA) supplemented with 10% fetal bovine 
serum and 1% penicillin/streptomycin (Life Tech-
nologies) and incubated in a humidified chamber 
at 37°C using a mixture of 95% air and 5% CO2. 
Confluent RAW264.7 cells were then activated with 
lipopolysaccharide (LPS, 100 ng/mL, Escherichia coli 
serotype 0127:B8 endotoxin; Sigma-Aldrich, St. Louis, 
MO, USA) to induce the expression of the various mole-
cules to be investigated, as previously reported [13].
2.2. Experimental protocols
Confluent RAW264.7 cells were randomly allocated 
into five groups. (1) The PBS group: RAW264.7 cells 
were treated with 1× phosphate buffered saline (PBS, 
Life Technologies). (2) The LPS group: RAW264.7 cells 
were treated with LPS (100 ng/mL; Sigma-Aldrich). 
(3) The M group: RAW264.7 cells were treated with 
MgSO4 (20 mM; Sigma-Aldrich). (4) The LPS + M group: 
RAW264.7 cells were treated with LPS plus MgSO4 
(20 mM). (5) The LPS + M + K group: RAW264.7 cells 
were treated with LPS plus MgSO4 (20 mM) plus a po-
tent L-type calcium channel activator BAY-K8644 (1 μM; 
Sigma-Aldrich). The doses of MgSO4 and BAY-K8644 
were determined based on our previous data, which 
indicated that MgSO4 at 20 mM was able to attenuate 
endotoxin-induced upregulation of inflammatory cyto-
kines in RAW264.7 cells and that BAY-K8644 at 1 μM 
was able to reverse the abovementioned effects of 
MgSO4 [9]. MgSO4 was administered immediately after 
LPS. BAY-K8644 was administered 5 minutes prior to 
LPS and was followed by MgSO4. Each group contained 
24 culture dishes (n = 24 in each group). For the anal-
ysis of AP-1, six culture dishes from each group were 
harvested after reacting with LPS for 0, 1, 3, and 5 
hours. Similar durations were used for the groups 
without LPS.
2.3. Nuclear extract preparation and 
immunoblotting assay
To facilitate assaying the activation of AP-1, including 
c-Jun and c-Fos, nuclear extracts were prepared as 
previously reported [13]. In brief, cells were washed, 
scraped, and centrifuged at 1500g for 5 minutes. The 
cell pellet was resuspended in 5 mL of cell lysis buffer 
[10 mM HEPES (pH 7.9), 1.5 mM MgCl2, 10 mM KCl, and 
0.6% NP-40; all chemicals were purchased from Sigma-
Aldrich] and centrifuged again at 1500g for 5 min-
utes. Cells were resuspended again in cell lysis buffer 
and allowed to swell on ice for 10 minutes followed 
by homogenization. The homogenate was centrifuged 
at 3300g for 15 minutes at 4°C. After discarding the 
supernatant, the pellet was resuspended and homog-
enized in three volumes of nuclear extraction buffer 
[20 mM HEPES (pH 7.9), 1.5 mM MgCl2, 420 mM NaCl, 
0.2 mM EDTA, and 25% glycerol; Sigma-Aldrich]. After 
stirring on ice for 30 minutes and centrifuging at 
89,000g for 30 minutes, the supernatant from the 
nuclear suspension was collected and concentrated in 
a Microcon 10 concentrator (Millipore Corp., Burlington, 
MA, USA) by centrifugation at 14,000g for 3 hours 
at 4°C. The protein concentration of each sample 
was measured using a BCA protein assay kit (Pierce 
Biotechnology Inc., Rockfold, IL, USA).
For immunoblotting, equal amounts of protein (65 μg) 
were loaded into each well of a 7.5% Tris-glycine pre-
cast polyacrylamide gel (Bio-Rad Laboratories, Hercules, 
CA, USA) and separated by electrophoresis. After sep-
aration, the proteins were transferred from the gel to 
nitrocellulose membrane (Bio-Rad Laboratories). The 
nitrocellulose membrane was then incubated over-
night at 4°C in primary antibody solution, namely 
c-Jun (1:500 dilution, polyclonal c-Jun antibody; Cell 
Signaling Technology Inc., Danvers, MA, USA), c-Fos 
(1:500 dilution, polyclonal c-Fos antibody; Cell Signaling 
Technology Inc.), or histone H3 (as an internal stan-
dard, 1:500 dilution, polyclonal histone H3 antibody; 
Cell Signaling Technology Inc.).
Horseradish peroxidase conjugated anti-mouse 
IgG antibody (Amersham Pharmacia Biotech Inc., 
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Piscataway, NJ, USA) was next used as the secondary 
antibody. Bound antibody was detected by chemi-
luminescence (ECL plus kit; Amersham Pharmacia 
Biotech Inc.) and high performance film (Hyperfilm; 
Amersham Pharmacia Biotech Inc.). The protein band 
densities were quantified using densitometry (Scion 
Corp., Frederick, MD, USA).
2.4. Immunofluorescent staining for AP-1
We chose to employ immunofluorescent staining to 
elucidate the effect of MgSO4 on AP-1 nuclear trans-
location. To facilitate immunofluorescent staining, 
RAW264.7 cells were treated with PBS, MgSO4, LPS, 
LPS plus MgSO4, or LPS plus MgSO4 plus BAY-K8644 
and harvested at 1 hour after the start of treatment. 
The timings for cell harvesting were based on the 
preliminary c-Jun data obtained from the immuno-
blotting assays. After harvesting, immunofluorescent 
staining was performed as previously described [14]. 
In brief, RAW264.7 cells were fixed with freshly pre-
pared 3% formaldehyde at room temperature for 
5 minutes and permeabilized by 0.5% Triton X-100 
(Sigma-Aldrich) on ice for 5 minutes. Cells were then 
rinsed twice with 1× PBS. After 30 minutes of block-
ing with 1% bovine serum albumin (Sigma-Aldrich), 
the RAW264.7 cells were then incubated in c-Jun 
primary antibody solution (1:100 dilution, polyclonal 
c-Jun antibody; Cell Signaling Technology Inc.) for 
30 minutes followed by incubation with fluorescent 
rhodamine isothiocyanate-conjugated secondary an-
tibody (Jackson ImmunoResearch Inc., West Grove, 
PA, USA) for 30 minutes. Nuclei were counterstained 
with diamidino-2-phenylindole (Pierce Biotechnology 
Inc.) and the cells were viewed using a microscope.
2.5. Electrophoretic mobility shift assay 
(EMSA)
After the RAW264.7 cells had been treated with PBS, 
MgSO4, LPS, LPS plus MgSO4, or LPS plus MgSO4 plus 
BAY-K8644, they were harvested 1 hour after treatment 
began in order to facilitate EMSA analysis of AP-1. 
After harvesting, nuclear extracts were prepared, as 
described above. EMSA was then performed using a 
chemiluminescence EMSA kit (AP-1 EMSA kit, respec-
tively; Panomics Inc., Fremont, CA, USA), as previously 
described [15].
2.6. Statistical analysis
One way analysis of variance was performed to test 
the between-group differences. The Tukey test was 
used for multiple comparisons. Data are presented 
as mean ± standard deviation. The significance level 
was set at 0.05. A commercial software package 
(SPSS 11.5 for Windows; SPSS Inc., Chicago, IL, USA) 
was used for data analyses.
3. Results
3.1. MgSO4 inhibited LPS-induced AP-1 
activation
PBS or MgSO4 had no significant effect on AP-1 ex-
pression, based on the fact that the c-Jun and c-Fos 
protein concentrations from the PBS and M groups were 
low throughout the experiments (data not shown). In 
contrast, the c-Jun and c-Fos protein concentrations 
of the LPS group, from cell cultures harvested at 1, 3, 
and 5 hours after LPS administration, were significantly 
higher than those of the PBS group (all p < 0.001, 
data not shown). Moreover, the c-Jun protein concen-
trations of the LPS + M group, from cell cultures har-
vested at 1, 3, and 5 hours after LPS administration, 
were significantly lower than those of the LPS group 
(p = 0.023, 0.025, and 0.011, respectively; Fig. 1). The 
c-Fos protein concentrations of the LPS + M group, 
from cell cultures harvested at 1 and 3 hours after 
LPS administration, were also significantly lower than 
those of the LPS group (p = 0.005 and 0.001, respec-
tively; Fig. 1).
AP-1 nuclear translocation was evaluated by immuno-
fluorescent staining. The immunfluorescent staining 
results confirmed that LPS induced significant AP-1 
nuclear translocation, as the fluorescence intensity 
of the LPS group was stronger than that of the PBS 
group (data not shown). Moreover, MgSO4 signifi-
cantly inhibited the effect of LPS on the induction of 
AP-1 nuclear translocation as the fluorescence inten-
sity of the LPS + M group was weaker than that of the 
LPS group (Fig. 2).
The AP-1 DNA-binding activity of the PBS group was 
low (Fig. 3A). The AP-1 DNA-binding activity of the 
M group was comparable to that of the PBS group, 
whereas the AP-1 DNA-binding activity of the LPS 
group was significantly higher than that of the PBS 
group (p < 0.001; Fig. 3A). Moreover, the AP-1 DNA-
binding activity of the LPS + M group was significantly 
lower than that of the LPS group (p = 0.021; Fig. 3).
3.2. Effects of MgSO4 on AP-1 were reversed 
by BAY-K8644
The c-Jun protein concentrations of the LPS + M + K 
group in cell cultures harvested at 1 and 5 hours 
after LPS administration were significantly higher than 
those of the LPS + M group (p = 0.036 and 0.019, re-
spectively; Fig. 1). The c-Fos protein concentrations 
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Fig. 1 — Representative gel photography and densitometric analysis of the nuclear protein concentrations of activator 
protein-1 (AP-1), including c-Jun and c-Fos, in the nuclear extracts of RAW264.7 cells after treatment with lipopolysac-
charide (LPS), LPS plus magnesium sulfate (MgSO4), and LPS plus MgSO4 plus the potent L-type calcium channel acti-
vator BAY-K8644 (denoted as the LPS, LPS + M, and LPS + M + K groups, respectively). The c-Jun and c-Fos concentrations 
were normalized against histone H3. Data are expressed as mean ± standard deviation. *p < 0.05, LPS + M group vs. LPS 
group; †p < 0.05, LPS + M + K group vs. LPS + M group.
0.0
0
c-
Ju
n
/h
is
to
n
e 
H
3
re
la
ti
ve
 d
en
si
ty
1
∗
3 5
Time (hr) after LPS
0.2
0.4
0.6 ∗
∗
∗
†
† †
†
∗
†
0.8
1.0
1.2
0.0
0
c-
Fo
s/
h
is
to
n
e 
H
3
re
la
ti
ve
 d
en
si
ty
1 3 5
Time (hr) after LPS
0.2
0.4
0.6
0.8
1.0
1.2
LPS
LPS + M
LPS + M + K
LPS
LPS + M
LPS + M + K
LPS
0
c-Jun
c-Fos
Histone H3
1 3 5 0 1 3 5 0 1 3 5
48 kDa
62 kDa
17 kDa
Time (hr) after LPS Time (hr) after LPS Time (hr) after LPS
LPS + M LPS + M + K
of the LPS + M + K group in cell cultures harvested at 
1, 3, and 5 hours after LPS administration were also 
significantly higher than those of the LPS + M group 
(p = 0.017, 0.033, and 0.025, respectively; Fig. 1). 
The fluorescence intensity of the LPS + M + K group 
was stronger than that of the LPS + M group (Fig. 2). 
Moreover, the AP-1 DNA-binding activity of the LPS + 
M + K group was significantly higher than that of the 
LPS + M group (p = 0.026; Fig. 3).
4. Discussion
The results from this study confirm our hypothesis 
that MgSO4 is able to attenuate AP-1 activation in 
endotoxin-activated murine macrophages. The cru-
cial role of AP-1 in the upregulation of inflammatory 
molecules during sepsis is well-established [4]. Our 
results, in concert with previous ones [9,10], confirm 
the potent anti-inflammation capacity of MgSO4. In addi-
tion, these results provide clear evidence to support 
the notion that MgSO4, in order to exhibit its anti-
inflammation effects, may act by inhibiting endotoxin-
induced AP-1 activation.
Endotoxin induces a transient increase in intracellu-
lar calcium level due to an initial intracellular calcium 
release followed by calcium influx from the extracel-
lular space [16]. This endotoxin-induced transient in-
crease in intracellular calcium plays a crucial role in 
regulating the expression of the signaling pathways 
and subsequent inflammatory molecules, as expres-
sion of these signaling pathways and the inflamma-
tory molecules are inhibited by calcium chelators [16]. 
The L-type calcium channels are members of a trans-
membrane ion channel group of proteins that are as-
sociated with calcium influx signaling in immune 
cells [17]. As mentioned earlier, magnesium is a nat-
ural calcium antagonist and a potent calcium chan-
nel inhibitor [11]. The results from this study reveal 
that the effects of MgSO4 on inhibiting AP-1 activation 
are significantly reversed by the L-type calcium channel 
activator BAY-K8644. This supports the notion that 
MgSO4 may act by inhibiting calcium influx from the 
extracellular space via the L-type calcium channels 
and that this leads to its inhibition of AP-1 activation.
Cellular recognition of endotoxin, including the 
binding of endotoxin to inflammatory cells and sub-
sequent toll-like receptor 4 (TLR-4) activation, has 
been shown to play an essential role in mediating 
endotoxin-induced activation of AP-1 [18]. Cellular rec-
ognition of endotoxin also involves the membrane-
anchor protein complex cluster of differentiation-14 
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Fig. 2 — Representative immunofluorescent staining findings for activator protein-1 (AP-1) nuclear translocation of 
RAW264.7 cells after treatment with lipopolysaccharide (LPS), LPS plus magnesium sulfate (MgSO4), and LPS plus 
MgSO4 plus the potent L-type calcium channel activator BAY-K8644 (denoted as the LPS, LPS + M, and LPS + M + K groups, 
respectively). AP-1 (c-Jun) was stained with fluorescent rhodamine isothiocyanate-conjugated antibody. The nuclei 
were counterstained with diamidino-2-phenylindole. The cells were imaged using a fluorescence microscope.
Fig. 3 — (A) Representative gels showing activator protein-1 (AP-1) DNA-binding activity in the nuclear extracts of 
RAW264.7 cells after treatment with phosphate buffered saline (PBS), lipopolysaccharide (LPS), LPS plus magnesium sul-
fate (MgSO4), and LPS plus MgSO4 plus the potent L-type calcium channel activator BAY-K8644 (denoted as the PBS, LPS, 
LPS + M, and LPS + M + K groups, respectively) by chemiluminescence electrophoretic mobility shift assay. (B) Densitometric 
analyses of the band intensities of the LPS, LPS + M and LPS + M + K groups. *p < 0.05, LPS + M group vs. LPS group; 
†p < 0.05, LPS + M + K group vs. LPS + M group.
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(CD14) [18,19]. After binding, endotoxin induces a 
physical proximity of CD14 and TLR-4 that allows CD14 
to present endotoxin to TLR-4, which then leads to the 
activation of intracellular signaling pathways [18,19]. 
Direct evidence delineating the effect of MgSO4 on 
the regulation of endotoxin binding to inflammatory 
cells and endotoxin-induced TLR-4 and CD14 activa-
tion is still lacking. Magnesium is an antagonist of the 
N-methyl-D-aspartate (NMDA) receptors [20]. Previous 
findings have indicated that inhibition of the NMDA 
receptors may result in an attenuation of TLR-4 activa-
tion [21]. Other results have indicated that rats fed a 
magnesium-deficient diet show enhanced CD14 expres-
sion in their intestinal and cardiac tissues [22]. These 
results seem to suggest the possibility that endotoxin-
induced TLR-4 and/or CD14 activation may be regu-
lated by MgSO4. In addition, myeloid differential-2 
(MD-2), an extracellular protein associated with the 
extracellular domain of TLR-4, is also required for 
the activation of TLR-4 by endotoxin [18]. MD-2 com-
prises a cationic and a hydrophobic binding site [23]. 
As magnesium is a divalent cation, we speculate that 
endotoxin-induced MD-2 activation might also be reg-
ulated by MgSO4. A follow-up study is currently being 
conducted in our laboratory to elucidate the effects 
of MgSO4 on the regulation of endotoxin-inflammatory 
cells binding and the endotoxin-induced TLR-4/CD14/
MD-2 complex.
Certain limitations to this study exist. First, although 
the findings of this study are in agreement with those 
of previous studies [9,10] and confirm the potent 
anti-inflammatory capacity of MgSO4, the effects of 
MgSO4 in terms of protecting vital organs from the 
detrimental effects of endotoxin remain unstudied. 
Second, while our results confirm the involvement 
of L-type calcium channels in mediating the anti-
inflammatory effects of MgSO4, this leaves unanswered 
the potential roles of the other calcium channels, 
which remain to be determined. Third, the question 
of whether the anti-inflammatory effects of MgSO4 
are also involved in other crucial mechanisms, such 
as the NMDA receptors, remains unanswered. Fourth, 
it is important to bear in mind that interspecies dif-
ferences need to be considered when extending the 
interpretation of the present results.
In conclusion, MgSO4 inhibited AP-1 activation in 
LPS-treated macrophages and the mechanisms would 
seem to involve the L-type calcium channels.
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